Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-017-4191-y
In the original publication of the article, the eighth and ninth co-author’s affiliations were published incorrectly. The correct affiliations of the co-authors are given in this erratum.
In Abstract, the sentence that reads as, “In this cohort,..... in the high vs low StrTIL group (64% vs 10%, p = 0.003).” should read as “In this cohort,....... in the low vs high StrTIL group (64% vs 10%, p = 0.003).”
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s10549-017-4191-y.
Rights and permissions
About this article
Cite this article
Dieci, M.V., Frassoldati, A., Generali, D. et al. Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials. Breast Cancer Res Treat 163, 637 (2017). https://doi.org/10.1007/s10549-017-4219-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-017-4219-3